Answers are grounded in this paper and cite their sources.
The Centers for Disease Control and Prevention (CDC) recommends oseltamivir phosphate for children <2 years old with confirmed or suspected influenza as they are at high risk for complications. We analyzed infant characteristics associated with nonprescription of oseltamivir over 9 years.
No takes yet. Share an insight, caveat, or question.
Zaheer et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: